Product Description: Fusion glycoprotein 92-106 is a polypeptide from fusion protein of respiratory syncytial virus (RSV). Fusion glycoprotein 92-106 acts as MHC class I-restricted CTL epitope, that all 15 amino acids are required for efficient recognition by cytotoxic T lymphocyte (CTL)[1].
Applications: COVID-19-anti-virus
Formula: C73H124N22O25S
References: [1]Jiang S, et al., Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus. J Gen Virol. 2002 Feb;83(Pt 2):429-438.
CAS Number: 406477-46-1
Molecular Weight: 1741.96
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: RSV